Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Sinntaxis

Today there is no drug for repairing the brain in stroke patients who have had serious brain injuries. They are left with rehabilitation to get back some of their ability in motion and speech. The company Sinntaxis AB is set out to develop a drug that can improve the rehabilitation of this patient group.

Sinntaxis AB's website

Sinntaxis

Developing novel therapeutics that enhance recovery of brain functions after stroke.

Founded by Tadeusz Wieloch, Roger Olsson, Carin Sjölund, Karsten Ruscher and Kerstin Beirup.

Portfolio company since 2017.

Portfolio Manager LU Holding:

christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), phone +46 70 928 63 78

8 Sep 2020